Waterloo Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Waterloo Capital's PFE Position: Q1 2026 in Review
Waterloo Capital increased its Pfizer (PFE) stake by 30% in Q1 2026, buying an estimated $210K and bringing the position to 34,043 shares worth $956K. The position accounts for 0.07% of the portfolio, ranked #214.
Waterloo Capital first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.7M in Q1 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Waterloo Capital held 34,043 shares of Pfizer worth $956K as of Q1 2026.
- Waterloo Capital bought 7,882 Pfizer shares in Q1 2026, an estimated $210K.
- Pfizer made up 0.07% of Waterloo Capital's portfolio in Q1 2026, its #214 holding.
- Waterloo Capital first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- Waterloo Capital's Pfizer position peaked at $1.7M in Q1 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.